Cargando…
Deletion of Cd39/Entpd1 Results in Hepatic Insulin Resistance
OBJECTIVE—Extracellular nucleotides are important mediators of inflammatory responses and could also impact metabolic homeostasis. Type 2 purinergic (P2) receptors bind extracellular nucleotides and are expressed by major peripheral tissues responsible for glucose homeostasis. CD39/ENTPD1 is the dom...
Autores principales: | Enjyoji, Keiichi, Kotani, Ko, Thukral, Chandrashekar, Blumel, Benjamin, Sun, Xiaofeng, Wu, Yan, Imai, Masato, Friedman, David, Csizmadia, Eva, Bleibel, Wissam, Kahn, Barbara B., Robson, Simon C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518482/ https://www.ncbi.nlm.nih.gov/pubmed/18567823 http://dx.doi.org/10.2337/db07-1265 |
Ejemplares similares
-
Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice
por: De Giorgi, Marco, et al.
Publicado: (2017) -
Functional ENTPD1 Polymorphisms in African Americans With Diabetes and End-Stage Renal Disease
por: Friedman, David J., et al.
Publicado: (2009) -
The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis
por: Peng, Zhen‐Wei, et al.
Publicado: (2017) -
Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19
por: Wang, Na, et al.
Publicado: (2021) -
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models
por: Zhang, Haohai, et al.
Publicado: (2022)